Printed aftercare leaflets are not medical devices and therefore do not carry CE marking or MHRA authorisation themselves.
Leaflets reference Kairax hyaluronic acid dermal filler, which is described by the brand as a fully CE Approved product containing lidocaine.
Printed aftercare leaflets are not medical devices and therefore do not carry CE marking or MHRA authorisation themselves.
Leaflets reference Kairax hyaluronic acid dermal filler, which is described by the brand as a fully CE Approved product containing lidocaine.
Dermal filler aftercare leaflets
Description
KAIRAX Aftercare leaflets x20 are branded patient-information leaflets designed to support clinics using Kairax hyaluronic acid dermal fillers. Each leaflet provides post-treatment guidance specific to Kairax filler procedures, including how to care for the treated area, what sensations to expect during the healing period, and tips to optimise treatment results. The pack contains 20 printed leaflets, allowing practitioners to give clear, consistent aftercare instructions to every Kairax patient.
Pack format: 20 individual Kairax aftercare leaflets per pack
Leaflet content: Kairax-specific dermal filler aftercare guidance (care of treated area, expected sensations, optimisation tips)
Exact leaflet size, page count and layout are not specified in publicly available listings
Packaging
Supplied as a single retail pack containing 20 Kairax aftercare leaflets
Leaflets are bundled/packed together for clinic use (exact wrapping or banding method not specified)
Pack labelled online as "KAIRAX Aftercare leaflets x20" with price and stock status
Usage
Intended for use by clinics and qualified practitioners who perform Kairax dermal filler treatments.
After completing a Kairax procedure, provide one leaflet to each patient and go through the key points verbally.
Advise patients to keep the leaflet and refer to it during the first days after treatment for guidance on normal post-treatment sensations and care instructions.
Typical aftercare guidance (as commonly provided for HA dermal fillers) may include: avoiding touching or massaging the treated area unless instructed, avoiding make-up for several hours, avoiding extreme heat or cold, limiting alcohol and strenuous exercise for 24 hours, and using sunscreen.
Use the leaflet alongside clinic-specific consent forms and medical advice; it is not a substitute for professional clinical judgement.
Dispose of damaged or outdated leaflets and replace with current versions to ensure that information remains accurate and aligned with the latest Kairax guidance.
Contraindications
No direct medical contraindications apply to the leaflet itself.
Patients with visual or reading difficulties may require additional verbal or alternative-format instructions.
Clinical contraindications relate to Kairax dermal filler treatment and must be assessed separately by the treating practitioner.
Adverse Effects
No direct medical adverse effects are associated with the leaflet itself.
Risk of misunderstanding or non-compliance if the leaflet is not explained or if patients do not read it; practitioners should review key points verbally to minimise this risk.
Storage Conditions
Store leaflets in a cool, dry place away from direct sunlight to prevent fading or paper damage.
Keep flat or upright in a document holder to avoid creasing or tearing.
Avoid exposure to moisture, oils or treatment-room chemicals which could stain or damage the paper.
Monitor stock and replace with updated versions if the manufacturer or distributor releases revised aftercare information.
Duration
Not applicable; this is an informational aftercare product used to support the post-treatment period following Kairax dermal filler procedures.
Onset
Not applicable; the leaflet itself has no clinical effect but supports appropriate aftercare immediately after treatment and during the healing period.
